EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H26FN5O4S |
| Net Charge | 0 |
| Average Mass | 559.623 |
| Monoisotopic Mass | 559.16895 |
| SMILES | COc1cc(S(C)(=O)=O)ccc1Nc1nc2ccc(-c3ccc(NC(=O)[C@H](C)c4ccc(F)cc4)cc3)cn2n1 |
| InChI | InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1 |
| InChIKey | NRJKIOCCERLIDG-GOSISDBHSA-N |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bay-1161909 (CHEBI:757653) has role antineoplastic agent (CHEBI:35610) |
| bay-1161909 (CHEBI:757653) is a acetamides (CHEBI:22160) |
| INN | Source |
|---|---|
| empesertib | WHO MedNet |
| Synonyms | Source |
|---|---|
| Bay-1161909 | ChEMBL |
| (-)-BAY-1161909 | ChEMBL |
| BAY 1161909 | ChEMBL |
| BAY1161909 | ChEMBL |
| MPS1-IN-5 | ChEMBL |
| Citations |
|---|